Celsius Therapeutics Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
64
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$250M
Celsius Therapeutics General Information
Description
Developer of medicines designed to treat complex diseases such as autoimmunity and cancer. The company's medicines apply a systematic approach to single-cell sequencing, combining massive datasets and algorithms in order to discover precision therapies, enabling doctors to identify genes that causally contribute to disease.
Contact Information
Website
www.celsiustx.comCorporate Office
- 245 First Street
- 18th Floor
- Cambridge, MA 02142
- United States
Corporate Office
- 245 First Street
- 18th Floor
- Cambridge, MA 02142
- United States
Celsius Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 27-Jun-2024 | $250M | Completed | Clinical Trials - Phase 1 | ||
| 2. Early Stage VC (Series B) | 24-Mar-2022 | Completed | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC (Series A) | 15-May-2018 | $65M | $65M | Completed | Startup |
Celsius Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Celsius Therapeutics Comparisons
Industry
Financing
Details
Celsius Therapeutics Competitors (78)
One of Celsius Therapeutics’s 78 competitors is Intus Biosciences, a Venture Capital-Backed company based in Farmington, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intus Biosciences | Venture Capital-Backed | Farmington, CT | ||||
| Ventus Therapeutics | Venture Capital-Backed | Waltham, MA | ||||
| Enterome | Venture Capital-Backed | Paris, France | ||||
| CaroGen | Venture Capital-Backed | Farmington, CT | ||||
| Aegle Therapeutics | Venture Capital-Backed | Woburn, MA |
Celsius Therapeutics Patents
Celsius Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024257984-A1 | Anti-trem1 antibody agents, compositions, and uses thereof | Pending | 21-Apr-2023 | ||
| EP-4562056-A1 | Anti-trem1 antibody agents, compositions, and uses thereof | Pending | 21-Apr-2023 | ||
| US-20260242465-A1 | Anti-trem1 antibody agents, compositions, and uses thereof | Pending | 21-Apr-2023 | ||
| WO-2024220958-A1 | Anti-trem1 antibody agents, compositions, and uses thereof | Inactive | 21-Apr-2023 | ||
| WO-2024220958-A9 | Anti-trem1 antibody agents, compositions, and uses thereof | Inactive | 21-Apr-2023 | C07K16/2803 |
Celsius Therapeutics Signals
Celsius Therapeutics Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Amgen Ventures | Corporate Venture Capital | Minority | ||
| Amplitude Ventures | Venture Capital | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Catalio Capital Management | Venture Capital | Minority |
Celsius Therapeutics FAQs
-
When was Celsius Therapeutics founded?
Celsius Therapeutics was founded in 2018.
-
Where is Celsius Therapeutics headquartered?
Celsius Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Celsius Therapeutics?
Celsius Therapeutics has 64 total employees.
-
What industry is Celsius Therapeutics in?
Celsius Therapeutics’s primary industry is Discovery Tools (Healthcare).
-
Is Celsius Therapeutics a private or public company?
Celsius Therapeutics is a Private company.
-
What is the current valuation of Celsius Therapeutics?
The current valuation of Celsius Therapeutics is .
-
What is Celsius Therapeutics’s current revenue?
The current revenue for Celsius Therapeutics is .
-
How much funding has Celsius Therapeutics raised over time?
Celsius Therapeutics has raised $148M.
-
Who are Celsius Therapeutics’s investors?
Alexandria Venture Investments, Amgen Ventures, Amplitude Ventures, Casdin Capital, and Catalio Capital Management are 5 of 11 investors who have invested in Celsius Therapeutics.
-
Who are Celsius Therapeutics’s competitors?
Intus Biosciences, Ventus Therapeutics, Enterome, CaroGen, and Aegle Therapeutics are some of the 78 competitors of Celsius Therapeutics.
-
When was Celsius Therapeutics acquired?
Celsius Therapeutics was acquired on 27-Jun-2024.
-
Who acquired Celsius Therapeutics?
Celsius Therapeutics was acquired by AbbVie.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process